What does PHARMACIE DEWAELE-WITDOUCK do?

PHARMACIE DEWAELE-WITDOUCK is a logistics company in Frasnes-lez-Anvaing. Public Limited, started on 20 March 2000, 1 establishment.

What is the address of PHARMACIE DEWAELE-WITDOUCK?

The registered office of PHARMACIE DEWAELE-WITDOUCK is located at Rue du Plit(A) 10, 7910 Frasnes-lez-Anvaing.

Is PHARMACIE DEWAELE-WITDOUCK still active?

Yes. According to the CBE (30 October 2026) PHARMACIE DEWAELE-WITDOUCK is active, legal situation “Normale toestand”, started on 20 March 2000.

Is PHARMACIE DEWAELE-WITDOUCK registered on Peppol?

Yes, PHARMACIE DEWAELE-WITDOUCK is registered on the Peppol network with ID 0208:0471463649.

What is the enterprise number of PHARMACIE DEWAELE-WITDOUCK?

The enterprise number of PHARMACIE DEWAELE-WITDOUCK is BE0471463649.

When was PHARMACIE DEWAELE-WITDOUCK founded?

PHARMACIE DEWAELE-WITDOUCK was founded on 20 March 2000.

Who are the directors of PHARMACIE DEWAELE-WITDOUCK?

According to the 2025 annual accounts, the directors of PHARMACIE DEWAELE-WITDOUCK are: Mélanie Witdouck, Melvin Dewaele.

Is PHARMACIE DEWAELE-WITDOUCK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 March 2000; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE DEWAELE-WITDOUCK make in 2025?

PHARMACIE DEWAELE-WITDOUCK posted a profit after taxes of € 264,741 in financial year 2025.

What is the revenue of PHARMACIE DEWAELE-WITDOUCK?

As a small company, PHARMACIE DEWAELE-WITDOUCK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 367,032.

How much does an employee at PHARMACIE DEWAELE-WITDOUCK earn?

The average wage cost per full-time employee at PHARMACIE DEWAELE-WITDOUCK was € 44,400 in 2025: staff costs of € 44,411 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DEWAELE-WITDOUCK have?

According to the 2025 annual accounts, PHARMACIE DEWAELE-WITDOUCK has 1 full-time equivalents (FTE).

PHARMACIE DEWAELE-WITDOUCK (Public Limited)

Dossier PHARMACIE DEWAELE-WITDOUCK, printed on 30 October 2026 from databakkes.be/en/0471463649/pharmacie-dewaele-witdouck. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DEWAELE-WITDOUCK from Frasnes-lez-Anvaing, company number BE0471463649, closed financial year 2025 with a result of € 264,741 after tax. For that financial year PHARMACIE DEWAELE-WITDOUCK recorded a gross margin of € 367,032 and equity of € 463,720. Compared with financial year 2024, the result moved from € 295,044 to € 264,741. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.

What it is worth Growing

€ 463,720

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 264,741

▼ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 609,659

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 263,000 paid out

99 % of the profit went to the shareholders, mostly to MELVIN DEWAELE (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 44,411

▼ 5% vs 2024

€ 44,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 12,099

▼ 49% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 32,718

▼ 44% vs 2024

€ 28,330 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 193,145

▼ 56% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 6,892

▼ 59% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 351,150 Gross margin 2022: € 351,150 First fiscal year in the series	€ 324,161 Gross margin 2023: € 324,161 ▼ 8% vs 2022 (€ 351,150) Unfavourable step	€ 394,457 Gross margin 2024: € 394,457 ▲ 22% vs 2023 (€ 324,161) Favourable step	€ 367,032 Gross margin 2025: € 367,032 ▼ 7% vs 2024 (€ 394,457) Unfavourable step	▼ 7%
Profit after taxes	€ 259,084 Profit after taxes 2022: € 259,084 First fiscal year in the series	€ 226,996 Profit after taxes 2023: € 226,996 ▼ 12% vs 2022 (€ 259,084) Unfavourable step	€ 295,044 Profit after taxes 2024: € 295,044 ▲ 30% vs 2023 (€ 226,996) Favourable step	€ 264,741 Profit after taxes 2025: € 264,741 ▼ 10% vs 2024 (€ 295,044) Unfavourable step	▼ 10%
Equity	€ 456,939 Equity 2022: € 456,939 First fiscal year in the series	€ 458,935 Equity 2023: € 458,935 Unchanged (€ 456,939) Favourable step	€ 461,979 Equity 2024: € 461,979 ▲ 1% vs 2023 (€ 458,935) Favourable step	€ 463,720 Equity 2025: € 463,720 Unchanged (€ 461,979) Favourable step
Total debts	€ 724,789 Total debts 2022: € 724,789 First fiscal year in the series	€ 760,081 Total debts 2023: € 760,081 ▲ 5% vs 2022 (€ 724,789) Unfavourable step	€ 806,305 Total debts 2024: € 806,305 ▲ 6% vs 2023 (€ 760,081) Unfavourable step	€ 737,787 Total debts 2025: € 737,787 ▼ 8% vs 2024 (€ 806,305) Favourable step	▼ 8%
Cash	€ 556,889 Cash 2022: € 556,889 First fiscal year in the series	€ 559,533 Cash 2023: € 559,533 Unchanged (€ 556,889) Favourable step	€ 564,202 Cash 2024: € 564,202 ▲ 1% vs 2023 (€ 559,533) Favourable step	€ 609,659 Cash 2025: € 609,659 ▲ 8% vs 2024 (€ 564,202) Favourable step	▲ 8%
Land & buildings	€ 277,401 Land & buildings 2022: € 277,401 First fiscal year in the series	€ 256,565 Land & buildings 2023: € 256,565 ▼ 8% vs 2022 (€ 277,401) Unchanged	€ 299,052 Land & buildings 2024: € 299,052 ▲ 17% vs 2023 (€ 256,565) Unchanged	€ 271,614 Land & buildings 2025: € 271,614 ▼ 9% vs 2024 (€ 299,052) Unchanged	▼ 9%
Retained profit	€ 303,245 Retained profit 2022: € 303,245 First fiscal year in the series	€ 305,241 Retained profit 2023: € 305,241 ▲ 1% vs 2022 (€ 303,245) Favourable step	€ 308,285 Retained profit 2024: € 308,285 ▲ 1% vs 2023 (€ 305,241) Favourable step	€ 310,026 Retained profit 2025: € 310,026 ▲ 1% vs 2024 (€ 308,285) Favourable step	▲ 1%
Dividend	€ 255,000 Dividend 2022: € 255,000 First fiscal year in the series	€ 225,000 Dividend 2023: € 225,000 ▼ 12% vs 2022 (€ 255,000) Unchanged	€ 292,000 Dividend 2024: € 292,000 ▲ 30% vs 2023 (€ 225,000) Unchanged	€ 263,000 Dividend 2025: € 263,000 ▼ 10% vs 2024 (€ 292,000) Unchanged	▼ 10%
Bank debt	€ 109,494 Bank debt 2022: € 109,494 First fiscal year in the series	€ 84,173 Bank debt 2023: € 84,173 ▼ 23% vs 2022 (€ 109,494) Favourable step	€ 58,581 Bank debt 2024: € 58,581 ▼ 30% vs 2023 (€ 84,173) Favourable step	€ 32,718 Bank debt 2025: € 32,718 ▼ 44% vs 2024 (€ 58,581) Favourable step	▼ 44%
Balance sheet total	€ 1,181,728 Balance sheet total 2022: € 1,181,728 First fiscal year in the series	€ 1,219,016 Balance sheet total 2023: € 1,219,016 ▲ 3% vs 2022 (€ 1,181,728) Unchanged	€ 1,268,284 Balance sheet total 2024: € 1,268,284 ▲ 4% vs 2023 (€ 1,219,016) Unchanged	€ 1,201,508 Balance sheet total 2025: € 1,201,508 ▼ 5% vs 2024 (€ 1,268,284) Unchanged	▼ 5%
Employees (FTE)	0.9 Employees (FTE) 2022: 0.9 First fiscal year in the series	1 Employees (FTE) 2023: 1 ▲ 0.1 vs 2022 (0.9) Unchanged	0 Employees (FTE) 2024: 0 ▼ 1 vs 2023 (1) Unchanged	1 Employees (FTE) 2025: 1 Unchanged (0) Unchanged

Key figures of PHARMACIE DEWAELE-WITDOUCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DEWAELE-WITDOUCK?

What happened at PHARMACIE DEWAELE-WITDOUCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Mélanie Witdouck stepped down as director. NBB
2029 Melvin Dewaele stepped down as director. NBB
Jul 13, 2026 New annual accounts for financial year 2025: profit of € 264,741 (▼ 10% vs 2024). Source: NBB ↗
2023 Mélanie Witdouck became a director. NBB
2023 Melvin Dewaele became a director. NBB
Apr 10, 2000 New establishment in Frasnes-lez-Anvaing. KBO
Mar 20, 2000 Start of the company according to the CBE. KBO

In short

From € 259,084 profit in 2022 to € 264,741 profit in 2025.

Paid € 6,146 in corporate taxes since 2022.

Best year ever: 2024, with € 295,044 profit.

On average € 367,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MELVIN DEWAELE 100%

The stake of MELVIN DEWAELE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE DEWAELE-WITDOUCK

The shares are held by MELVIN DEWAELE (100%).

Directors

According to the 2025 annual accounts

Mélanie Witdouck

Director

Also active at: MELVIN DEWAELE

since 2023 · until 2029

Melvin Dewaele

Director · represented by Dewaele Vincent

since 2023 · until 2029

Shareholders

MELVIN DEWAELE

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Plit(A) 10

7910 Frasnes-lez-Anvaing

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

ANPHAR

MELVIN DEWAELE same network

€ 267,772 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0471.463.649

VAT number

BE 0471.463.649

Registered office

Rue du Plit(A) 10, 7910 Frasnes-lez-Anvaing

Names & denominations

PHARMACIE DEWAELE-WITDOUCK

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

20 March 2000

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DEWAELE-WITDOUCK

Financials

What happened to PHARMACIE DEWAELE-WITDOUCK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions